INHA and cancer: Cancer types that presented different survival predictions for INHA, TGFBR3, or ENG were assessed (Fig 5a), and cancer types in which each gene would have a similar patient outcome (i.e., positive overall survival outcome vs. negative overall survival outcome) were separated into groups (e.g., INHA positive outcome vs. negative outcome, Fig 5a).